OPRX
Income statement / Annual
Last year (2024), OptimizeRx Corporation's total revenue was $92.13 M,
an increase of 28.81% from the previous year.
In 2024, OptimizeRx Corporation's net income was -$20.11 M.
See OptimizeRx Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$92.13 M |
$71.52 M |
$62.45 M |
$61.29 M |
$43.31 M |
$24.60 M |
$21.21 M |
$12.13 M |
$7.75 M |
$7.22 M |
| Cost of Revenue |
$32.75 M
|
$28.62 M
|
$23.48 M
|
$25.65 M
|
$19.21 M
|
$9.16 M
|
$9.00 M
|
$6.17 M
|
$3.41 M
|
$3.62 M
|
| Gross Profit |
$59.38 M
|
$42.90 M
|
$38.97 M
|
$35.64 M
|
$24.11 M
|
$15.44 M
|
$12.21 M
|
$5.95 M
|
$4.34 M
|
$3.60 M
|
| Gross Profit Ratio |
0.64
|
0.6
|
0.62
|
0.58
|
0.56
|
0.63
|
0.58
|
0.49
|
0.56
|
0.5
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.60 M
|
$675.66 K
|
$1.01 M
|
$398.40 K
|
$290.37 K
|
| General & Administrative Expenses |
$61.27 M
|
$58.02 M
|
$49.24 M
|
$27.51 M
|
$19.31 M
|
$13.66 M
|
$9.99 M
|
$6.54 M
|
$4.94 M
|
$3.27 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$5.68 M
|
$615.94 K
|
$709.01 K
|
$299.96 K
|
$207.06 K
|
$297.00 K
|
$47.93 K
|
| Selling, General & Administrative Expenses |
$61.27 M
|
$58.02 M
|
$49.24 M
|
$33.19 M
|
$19.93 M
|
$14.36 M
|
$10.29 M
|
$6.75 M
|
$5.24 M
|
$3.32 M
|
| Other Expenses |
$11.82 M
|
$11.28 M
|
$2.02 M
|
$2.09 M
|
$6.31 M
|
$3.16 M
|
$449.00 K
|
$324.55 K
|
$235.28 K
|
$583.95 K
|
| Operating Expenses |
$73.08 M
|
$69.30 M
|
$51.26 M
|
$35.28 M
|
$26.24 M
|
$19.13 M
|
$12.03 M
|
$8.08 M
|
$5.87 M
|
$4.20 M
|
| Cost And Expenses |
$105.83 M
|
$97.92 M
|
$74.74 M
|
$60.93 M
|
$45.45 M
|
$28.29 M
|
$21.03 M
|
$14.26 M
|
$9.28 M
|
$7.82 M
|
| Interest Income |
$329.00 K
|
$2.19 M
|
$852.30 K
|
$16.98 K
|
$68.58 K
|
$288.03 K
|
$46.21 K
|
$25.94 K
|
$42.31 K
|
$2.27 K
|
| Interest Expense |
$6.16 M
|
$1.45 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$4.33 M
|
$2.40 M
|
$2.02 M
|
$1.97 M
|
$1.97 M
|
$1.18 M
|
$316.50 K
|
$324.55 K
|
$235.28 K
|
$333.95 K
|
| EBITDA |
-$8.90 M |
-$21.31 M |
-$9.42 M |
$2.33 M |
$646.90 K |
-$1.51 M |
$1.24 M |
-$1.81 M |
-$1.30 M |
-$261.19 K |
| EBITDA Ratio |
-0.1
|
-0.3
|
-0.15
|
0.04
|
0.01
|
-0.06
|
0.06
|
-0.15
|
-0.17
|
-0.04
|
| Operating Income Ratio |
-0.15
|
-0.37
|
-0.2
|
0.01
|
-0.05
|
-0.15
|
0.01
|
-0.18
|
-0.2
|
-0.08
|
| Total Other Income/Expenses Net |
-$5.68 M
|
$1.24 M
|
$852.30 K
|
$16.98 K
|
-$71.81 K
|
$1.45 M
|
$46.21 K
|
$25.94 K
|
$42.31 K
|
$2.27 K
|
| Income Before Tax |
-$19.39 M
|
-$25.16 M
|
-$11.44 M
|
$378.08 K
|
-$2.21 M
|
-$2.24 M
|
$226.34 K
|
-$2.10 M
|
-$1.54 M
|
-$595.14 K
|
| Income Before Tax Ratio |
-0.21
|
-0.35
|
-0.18
|
0.01
|
-0.05
|
-0.09
|
0.01
|
-0.17
|
-0.2
|
-0.08
|
| Income Tax Expense |
$725.00 K
|
-$7.60 M
|
$0.00
|
$0.00
|
$0.00
|
$897.96 K
|
$0.00
|
$0.00
|
$0.00
|
$2.27 K
|
| Net Income |
-$20.11 M
|
-$17.57 M
|
-$11.44 M
|
$378.08 K
|
-$2.21 M
|
-$3.14 M
|
$226.34 K
|
-$2.10 M
|
-$1.54 M
|
-$595.14 K
|
| Net Income Ratio |
-0.22
|
-0.25
|
-0.18
|
0.01
|
-0.05
|
-0.13
|
0.01
|
-0.17
|
-0.2
|
-0.08
|
| EPS |
-1.1 |
-1.03 |
-0.64 |
0.0219 |
-0.15 |
-0.23 |
0.02 |
-0.21 |
-0.16 |
-0.0727 |
| EPS Diluted |
-1.1 |
-1.03 |
-0.64 |
0.0214 |
-0.15 |
-0.23 |
0.0191 |
-0.21 |
-0.16 |
-0.0727 |
| Weighted Average Shares Out |
$18.29 M
|
$17.12 M
|
$17.78 M
|
$17.23 M
|
$14.83 M
|
$13.39 M
|
$11.32 M
|
$9.82 M
|
$9.90 M
|
$8.19 M
|
| Weighted Average Shares Out Diluted |
$18.29 M
|
$17.12 M
|
$17.78 M
|
$17.69 M
|
$14.83 M
|
$13.39 M
|
$11.86 M
|
$9.82 M
|
$9.90 M
|
$8.19 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
